Since the NCI Site Visit to the UNM Cancer Center in May 2005 and receipt of the detailed CCSG review. The University of New Mexico Cancer Center has undertaken very extensive internal planning and evaluation. The Cancer Center initiated a strategic planning process to improve evaluation of the Cancer Center. We have held four full meetings of our UNM Cancer Center External Scientific Advisory Board (ESAB) in: November 2006, June 2007, and May 2008 and May, 2009. In addition, we have coordinated several visits to our institution from individual members of our ESAB or other invited experts to review each program or special activity. We have focused our analyses on our overall strategic plans and on the strengths, weaknesses, opportunities, focus, and design of each of our Research Programs, their Associated Clinical Working Groups, and our Shared Resources. We have carefully considered the detailed critiques provided by the NCI Review Panel for our P30 CCSG and our ESAB and individual consultants. We have had weekly meetings of the UNM Cancer Center Senior Leadership group for the past year and regular meetings of the Cancer Center Research Program, Clinical Working Group, and Shared Resource Directors. We have also activated an institution-wide Cancer Center Seminar Series held the 3rd and 4th Tuesday of each month, where selected Program Members present highlights of their science. This very popular luncheon seminar regulariy attracts over 50 Cancer Center-associated faculty as well as other faculty and staff from the Health Sciences Center;the series has further enhanced awareness and interactions among excellent program scientists. We have described our ongoing planning and evaluation activities in some detail in the Director's Scientific Overview (Section 6) and each of the Research Program Reports (Section 8). As previously described, over the past 4 years, we have made changes in our Senior Leadership, have appointed new Program Leaders, and have adjusted the focus and scope of our Research Programs, particulariy in Cancer Biology &Biotechnology. In part due to anticipation of our competitive renewal, we have also completed a new 5 year detailed Strategic Plan for the next phase of development of our Center overall, with specific plans for each of our Programs and Resources.

Public Health Relevance

UNM Cancer Center planning and evaluation processes are to responsive external review which facilitate the identification of areas of strength, weakness and opportunities and their incorporation into strategic planning.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA118100-09
Application #
8545052
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
9
Fiscal Year
2013
Total Cost
$73,943
Indirect Cost
Name
University of New Mexico Health Sciences Center
Department
Type
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Guo, Yan; Yu, Hui; Wang, Jing et al. (2018) The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer. Genes (Basel) 9:
Hatch, Ellen W; Geeze, Mary Beth; Martin, Cheyenne et al. (2018) Variability of PD-L1 expression in mastocytosis. Blood Adv 2:189-199
Frerich, Candace A; Brayer, Kathryn J; Painter, Brandon M et al. (2018) Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes. Oncotarget 9:7341-7358
Kinney, Anita Y; Howell, Rachel; Ruckman, Rachel et al. (2018) Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial. Contemp Clin Trials 73:123-135
Tasnim, Humayra; Fricke, G Matthew; Byrum, Janie R et al. (2018) Quantitative Measurement of Naïve T Cell Association With Dendritic Cells, FRCs, and Blood Vessels in Lymph Nodes. Front Immunol 9:1571
Leng, Shuguang; Diergaarde, Brenda; Picchi, Maria A et al. (2018) Gene Promoter Hypermethylation Detected in Sputum Predicts FEV1 Decline and All-Cause Mortality in Smokers. Am J Respir Crit Care Med 198:187-196
Castleman, Moriah J; Pokhrel, Srijana; Triplett, Kathleen D et al. (2018) Innate Sex Bias of Staphylococcus aureus Skin Infection Is Driven by ?-Hemolysin. J Immunol 200:657-668
Barton, Matthias; Filardo, Edward J; Lolait, Stephen J et al. (2018) Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives. J Steroid Biochem Mol Biol 176:4-15
Prossnitz, Eric R (2018) GPER modulators: Opportunity Nox on the heels of a class Akt. J Steroid Biochem Mol Biol 176:73-81
Perez, Dominique R; Nickl, Christian K; Waller, Anna et al. (2018) High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALL. SLAS Discov 23:732-741

Showing the most recent 10 out of 344 publications